Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare Licenses Nucleic Acid-Separation IP to NorDiag

NEW YORK (GenomeWeb News) — GE Healthcare has agreed to license certain of its patents for biomagnetic nucleic-acid isolation to screening and diagnostics company NorDiag, GE Healthcare said yesterday.
 
GE Healthcare said the IP differs from conventional nucleic acid-isolation techniques due to the fact that the increased yield of nucleic acids it can isolate from disease-causing pathogens allows “diagnosis from smaller-volume patient samples.”
 
NorDiag CEO Mårten Wigstøl said the license will enable the company “widen [its] portfolio of products for clinical diagnostics,” and show shareholders that the company can “bring in technologies from large players such as GE Healthcare.”

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.